ARTICLE | Company News
Cardiome, Eddingpharm deal
January 5, 2015 8:00 AM UTC
Cardiome granted Eddingpharm rights to develop and commercialize atrial fibrillation drug IV Brinavess vernakalant in China, including Macau, and Taiwan. Eddingpharm also has rights to re-launch the ...